(Q36864836)

16 August 2017

1 reference

title

Lymphoma risk in inflammatory bowel disease: is it the disease or its treatment? (English)

1 reference

inflammatory bowel diseases

16 August 2017

main subject

0 references

0 references

2

Edward V Loftus

1 reference

16 August 2017

Jennifer L Jones

1

1 reference

16 August 2017

publication date

1 October 2007

1 reference

Inflammatory Bowel Diseases

16 August 2017

published in

1 reference

16 August 2017

volume

13

1 reference

16 August 2017

issue

10

1 reference

16 August 2017

page(s)

1299-1307

1 reference

Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics

16 August 2017

cites work

1 reference

Host-flora interactions in inflammatory bowel disease.

21 January 2018

1 reference

Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Microbes, immunoregulation, and the gut.

21 January 2018

1 reference

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

Infliximab maintenance therapy for fistulizing Crohn's disease

21 January 2018

1 reference

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators

21 January 2018

1 reference

Inflammatory bowel diseases: clinical update of practical guidelines

21 January 2018

1 reference

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

21 January 2018

1 reference

The complicated path to true causes of disease: role of nuclear factor kappaB in inflammatory bowel disease

21 January 2018

1 reference

Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment

21 January 2018

1 reference

Review article: does the use of immunosuppressive therapy in inflammatory bowel disease increase the risk of developing lymphoma?

21 January 2018

1 reference

Epstein-Barr virus and post-transplant lymphoproliferative disease

21 January 2018

1 reference

Epstein-Barr virus viral load in Crohn's disease: effect of immunosuppressive therapy

21 January 2018

1 reference

Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France.

21 January 2018

1 reference

Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis

21 January 2018

1 reference

Epstein‐Barr virus load in the peripheral blood of patients with rheumatoid arthritis: Accurate quantification using real‐time polymerase chain reaction

21 January 2018

1 reference

Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County

21 January 2018

1 reference

Primary malignant lymphoma of the large intestine complicating chronic inflammatory bowel disease

21 January 2018

1 reference

Diffuse colonic mantle cell lymphoma in a patient with presumed ulcerative colitis: detection of a precursor monoclonal lymphoid population using polymerase chain reaction and immunohistochemistry

21 January 2018

1 reference

The incidence of lymphoid and myeloid malignancies among hospitalized Crohn's disease patients

21 January 2018

1 reference

Hodgkin's disease risk is increased in patients with ulcerative colitis.

21 January 2018

1 reference

Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark

21 January 2018

1 reference

Extracolonic malignancies in inflammatory bowel disease.

21 January 2018

1 reference

Risk of haematopoietic cancer in patients with inflammatory bowel disease

21 January 2018

1 reference

Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

21 January 2018

1 reference

Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment

21 January 2018

1 reference

Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine

21 January 2018

1 reference

Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low

21 January 2018

1 reference

The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents

21 January 2018

1 reference

Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine

21 January 2018

1 reference

Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine

21 January 2018

1 reference

Colorectal neoplasia in ulcerative colitis-recent advances

21 January 2018

1 reference

Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients

21 January 2018

1 reference

The mortality of rheumatoid arthritis

21 January 2018

1 reference

Safety of infliximab and other biologic agents in the inflammatory bowel diseases

21 January 2018

1 reference

Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease

21 January 2018

1 reference

The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients

21 January 2018

1 reference

Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County

21 January 2018

1 reference

Safety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis

21 January 2018

1 reference

Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas

21 January 2018

1 reference

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

21 January 2018

1 reference

Hepatosplenic T-gammadelta lymphoma in a patient with Crohn's disease treated with azathioprine

21 January 2018

1 reference

Risks and benefits of infliximab for the treatment of Crohn's disease

21 January 2018

1 reference

Exploring utilities and outcomes with infliximab therapy.

21 January 2018

1 reference

Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction

21 January 2018

1 reference

Methotrexate for the Treatment of Crohn's Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.20211

1 reference

16 August 2017

1 reference